Predictors of the early impairment of renal disease in human obesity (Q43254390)

17 November 2017

title

Predictors of the early impairment of renal disease in human obesity (English)

1 reference

17 November 2017

0 references

1 reference

L Gilardini

1

1 reference

17 November 2017

A Zulian

2

1 reference

17 November 2017

A Girola

3

1 reference

17 November 2017

G Redaelli

4

1 reference

17 November 2017

A Conti

5

1 reference

17 November 2017

C Invitti

6

1 reference

17 November 2017

language of work or name

English

0 references

publication date

27 October 2009

1 reference

International Journal of Obesity

17 November 2017

published in

1 reference

17 November 2017

volume

34

1 reference

17 November 2017

issue

2

1 reference

17 November 2017

page(s)

287-294

1 reference

Lowering the threshold for defining microalbuminuria: effects of a lifestyle-metformin intervention in obese "normoalbuminuric" non-diabetic subjects

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

Molecular cloning, chromosomal localization, tissue mRNA levels, bacterial expression, and enzymatic properties of human NMN adenylyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

Fatty acids and expression of adipokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Microalbuminuria, central adiposity and hypertension in the non-diabetic urban population of the MONICA Augsburg survey 1994/95.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Cardiovascular risk-factors predict progression of urinary albumin-excretion in a general, non-diabetic population: a gender-specific follow-up study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Impact of weight change on albuminuria in the general population

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Glomerular hemodynamics in severe obesity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

The effects of weight loss on renal function in patients with severe obesity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Effect of TNF-alpha inhibition on urinary albumin excretion in experimental diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Adiponectin is increased and correlated with the degree of proteinuria, but plasma leptin is not changed in patients with chronic glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Plasma adiponectin levels in chronic kidney disease patients: relation with molecular inflammatory profile and metabolic status

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Differential impacts of adiponectin on low-grade albuminuria between obese and nonobese persons without diabetes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

What predicts progression and regression of urinary albumin excretion in the nondiabetic population?

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

The effect of bariatric surgery on adipocytokines, renal parameters and other cardiovascular risk factors in severe and very severe obesity: 1-year follow-up

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Definition of Kidney Dysfunction as a Cardiovascular Risk Factor Use of Urinary Albumin Excretion and Estimated Glomerular Filtration Rate

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Metabolically healthy but obese individuals

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Obesity, insulin resistance and kidney disease risk: insights into the relationship

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

SOCS proteins causing trouble in insulin action

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Distinct impaired regulation of SOCS3 and long and short isoforms of the leptin receptor in visceral and subcutaneous fat of lean and obese women

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

The long pentraxin PTX3 in vascular pathology

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Expression of long pentraxin PTX3 in human adipose tissue and its relation with cardiovascular risk factors.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Characterization of the long pentraxin PTX3 as a TNFalpha-induced secreted protein of adipose cells

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Emerging role of adipose tissue hypoxia in obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Fatty acid synthase gene expression in human adipose tissue: association with obesity and type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Upregulation of lipogenic enzymes genes expression in white adipose tissue of rats with chronic renal failure is associated with higher level of sterol regulatory element binding protein-1.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Upregulation of fatty acid synthase gene expression in experimental chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.227

7 January 2021

Identifiers

DOI

10.1038/IJO.2009.227

1 reference

Dimensions Publication ID

17 November 2017

1040225217

0 references

Fatcat ID

release_frqnjpzugvbjffn6vv6g2wxlgu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/frqnjpzugvbjffn6vv6g2wxlgu

24 November 2022

mapped directly with Wikidata item

1 reference